Dosage Form: FOR ANIMAL USE ONLY
Medication for All Freshwater Fish - Fast Dissolving Powder Form
Indications and Usage for Sentry AQ Mardel Maracyn
For the treatment and control of body fungus "columnaris," fin and tail rot, popeye and gill disease in tetras, cichlids, livebearers, catfish and goldfish caused by Flavobacterium columnare, Haemophilus piscium, Aeromonus punctata, Aeromonus hydrophila and Cytophaga aquatilis bacteria.
Read enclosed brochure carefully before using. Use of a hospital tank is recommended. No water changes, pH or temperature adjustments necessary if readings are in ideal range. Maintain normal filtration and air.
INSTRUCTIONS
Add the contents of one packet per 10 gallons of water and repeat every 24 hours for 5 days. Repeat this 5 day treatment only once if needed. Important: Treat for 5 days even if visible signs disappear. May be used concurrently with Coppersafe, Maracide, Maracyn Two or Maroxy. Refer to enclosed fish disease chart for proper combination use.
KEEP OUT OF REACH OF CHILDREN
For aquarium use only. THIS PRODUCT IS INTENDED FOR THE EXCLUSIVE USE WITH ORNAMENTAL FISH AND/OR OTHER ORNAMENTAL ORGANISMS AND IS NOT INTENDED FOR USE WITH HUMANS OR FISH FOR HUMAN CONSUMPTION.
ACTIVE INGREDIENT
Each packet contains 200 mg erythromycin activity. Licensed under U.S. Patent 3,737,526.
How is Sentry AQ Mardel Maracyn Supplied
Net Contents:
8-0.021 oz. (0.6 g) Powder Packets
24-0.021 oz. (0.6 g) Powder Packets
PACKAGING COMPONENT
Sentry AQ Mardel Maracyn
Distributed by:
Sergeant's Pet Care Products, Inc., Omaha, NE 68130
www.sentrypetcare.com
| Sentry AQ Mardel Maracyn erythromycin powder | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | 02/06/2009 | ||
| Labeler - Sergeant's Pet Care Products, Inc. (876995171) |
No comments:
Post a Comment